A call for standardization for secretome and extracellular vesicles in osteoarthritis: results show disease-modifying potential, but protocols are too heterogeneous—a systematic review
Human Cell · 23.06.2024 · 37 (5) · 1243-1275
DOI: 10.1007/s13577-024-01084-9 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Human Cell, online erschienen am 23.06.2024. Verfasst von Daniele D'Arrigo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Technologies Laboratory, EOC, Via Francesco Chiesa 5, 6500, Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Osteoarthritis, Extracellular Vesicles, Mesenchymal Stem Cells, Secretome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 109 Literaturangaben.
Abstract (Originalsprache)
The currently available osteoarthritis (OA) treatments offer symptoms' relief without disease-modifying effects. Increasing evidence supports the role of human mesenchymal stem cells (MSCs) to drive beneficial effects provided by their secretome and extracellular vesicles (EVs), which includes trophic and biologically active factors. Aim of this study was to evaluate the in vitro literature to understand the potential of human secretome and EVs for OA treatment and identify trends, gaps, and potential translational challenges. A systematic review was performed on PubMed, Embase, and Web-of-Science, identifying 58 studies. The effects of secretome and EVs were analysed on osteoarthritic cells regarding anabolic, anti-apoptotic/anti-inflammatory and catabolic/pro-inflammatory/degenerative activity, chondroinduction, and immunomodulation. The results showed that MSC-derived EVs elicit an increase in proliferation and migration, reduction of cell death and inflammation, downregulation of catabolic pathways, regulation of immunomodulation, and promotion of anabolic processes in arthritic cells. However, a high heterogeneity in several technical or more applicative aspects emerged. In conclusion, the use of human secretome and EVs as strategy to address OA processes has overall positive effects and disease-modifying potential. However, it is crucial to reduce protocol variability and strive toward a higher standardization, which will be essential for the translation of this promising OA treatment from the in vitro research setting to the clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Regenerative Medicine Technologies Laboratory, EOC, Via Francesco Chiesa 5, 6500, Bellinzona, Switzerland.
- Laboratoire Matière et Systèmes Complexes, Université Paris Cité, 45 Rue des Saints Pères, 75006, Paris, France.
- Abbelight, Cachan, 191 Av. Aristide Briand, 94230, Cachan, France.
- Applied and Translational Research center, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136, Bologna, Italy. manuela.salerno@ior.it.
- Clinica Ortopedica e Traumatologica 2, IRCCS Istituto Ortopedico Rizzoli, Via Pupilli 1, 40136, Bologna, Italy.
- Applied and Translational Research center, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136, Bologna, Italy.
Zitieren
APA
D'Arrigo, D., Salerno, M., De Marziani, L., Boffa, A., & Filardo, G. (2024). A call for standardization for secretome and extracellular vesicles in osteoarthritis: results show disease-modifying potential, but protocols are too heterogeneous—a systematic review. Human Cell, 37(5), 1243-1275. https://doi.org/10.1007/s13577-024-01084-9
Vancouver
D'Arrigo D, Salerno M, De Marziani L, Boffa A, Filardo G. A call for standardization for secretome and extracellular vesicles in osteoarthritis: results show disease-modifying potential, but protocols are too heterogeneous—a systematic review. Human Cell. 2024;37(5):1243-1275. doi:10.1007/s13577-024-01084-9
BibTeX
@article{DArrigo2024,
author = {D'Arrigo, Daniele and Salerno, Manuela and De Marziani, Luca and Boffa, Angelo and Filardo, Giuseppe},
title = {A call for standardization for secretome and extracellular vesicles in osteoarthritis: results show disease-modifying potential, but protocols are too heterogeneous—a systematic review},
journal = {Human Cell},
year = {2024},
volume = {37},
number = {5},
pages = {1243--1275},
doi = {10.1007/s13577-024-01084-9}
}
EUVIMED